Single dose oral celecoxib for postoperative pain

Area of Science:

• Pharmacology
• Pain Management
• Clinical Trials

Background:

• Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is used for chronic pain in osteoarthritis and rheumatoid arthritis.
• It is presumed to have fewer adverse effects than traditional non-steroidal anti-inflammatory drugs (NSAIDs).
• The efficacy of celecoxib for acute pain has not been systematically reviewed.

Purpose of the Study:

• To evaluate the analgesic efficacy of a single oral dose of celecoxib for moderate to severe postoperative pain.
• To assess the adverse effects associated with single-dose oral celecoxib in postoperative pain management.

Main Methods:

• Systematic review of randomized controlled trials (RCTs) comparing oral celecoxib to placebo for acute postoperative pain.
• Searched databases including Cochrane Library, MEDLINE, Biological Abstracts, PubMed, and Oxford Pain database (up to May 2002).
• Extracted data on pain relief (at least 50% over 4-6 hours) to calculate relative benefit (RB) and number-needed-to-treat (NNT).

Main Results:

• The number-needed-to-treat (NNT) for celecoxib 200 mg was 4.5 (CI 3.3 to 7.2), indicating one additional patient achieved significant pain relief compared to placebo.
• The median time to remedication was 5.1 hours with celecoxib 200 mg versus 1.5 hours with placebo.
• No serious or unexpected adverse effects were reported, though quantitative analysis was not possible.

Conclusions:

• Single-dose oral celecoxib is effective for postoperative pain relief, with efficacy similar to aspirin and paracetamol.
• The reviewed trials used a 200 mg dose, which is 50% less than recommended for acute pain.
• Further trials are necessary to assess the efficacy of the recommended 400 mg dose and to gather pooled data on adverse effects.